Earnings Ahead

MEIP - MEI Pharma Inc.

6.5 0.17 2.69

  1. Home
  2. Healthcare
  3. MEIP
MEI Pharma Inc.

MEI Pharma Inc.

About

Profile

Headquarters

California, United States

Intraday

High
-
Low
-

52-week

High
-
Low
-

MEIP



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • MEI Pharma GAAP EPS of $0.08 beats by $0.29, revenue of $32.74M beats by $29.4M
  • MEI Pharma slumps on ending lead drug development ex-Japan, analysts downgrade stock
  • MEI Pharma to reduce workforce by about 30%, refocus development on earlier assets
  • MEI Pharma slumps ~34% after ending development of its cancer treatment outside of Japan
  • Mei Pharma releases top-line, mid-stage data on zandelisib for Non-Hodgkin’s Lymphoma
  • MEI Pharma GAAP EPS of -$0.12 beats by $0.04, revenue of $8.73M beats by $4.31M
  • MEI Pharma stock trades higher as FY22 revenue grows 17%
  • MEI Pharma GAAP EPS of -$0.50 misses by $0.03, revenue of $40.7M misses by $1.09M
  • MEI Pharma GAAP EPS of -$0.07 beats by $0.11, revenue of $9.7M beats by $6.26M
  • MEI Pharma to restate financials after errors in revenue recognition
  • MEI Pharma posts a historic drop as setback to cancer drug draws downgrades
  • MEI Pharma falls on setback to U.S. marketing application for lymphoma therapy
  • MEI Pharma GAAP EPS of -$0.09, revenue of $18.22M
  • MEI Pharma announces inducement grants of 155K shares to seven new employees
  • MEI Pharma raises $45.5M capital via stock offering
  • MEI Pharma launches offering of 17.5M common shares
  • MEI Pharma jumps 10% on promising zandelisib data in follicular lymphoma
  • MEI Pharma EPS misses by $0.01, beats on revenue
  • MEI Pharma and Kyowa Kirin get FDA orphan drug designation for zandelisib
  • MEI Pharma EPS misses by $0.11, beats on revenue
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.13 / -0.1314 13.39M / 10.56M Beat!
September 2, 2021 -0.0502 / -0.1686 10.12M / 4.17M Beat!
May 6, 2021 -0.28 / -0.1558 2.42M / 5.41M
February 4, 2021 -0.16 / -0.1317 9.17M / 2.92M Beat!
November 10, 2020 -0.13 / -0.082 3.83M / 4.29M
September 9, 2020 -0.17 / 0.22 25.5M / 45.07M
May 7, 2020 -0.04 / -0.13 1.24M / 1.58M
February 6, 2020 -0.26 / -0.16 1.01M / 1.58M
November 7, 2019 -0.04 / -0.17 1.16M / 1.33M
August 29, 2019 -0.15 / -0.19 1.13M / 715.86K
May 9, 2019 -0.24 / -0.17 1.25M / 690.71K
February 7, 2019 -0.15 / -0.14 2.05M / 2.09M
November 8, 2018 -0.21 / -0.12 488K / 464K Beat!
August 30, 2018 -0.36 / -0.19 552K / 433.75K Beat!
May 9, 2018 -0.16 / -0.24 433K / 200K Beat!
September 5, 2017 -0.12 / -0.27 449.0K / - Beat!
May 4, 2017 -0.02 / -0.16 4.51M / - Beat!
February 3, 2017 0.32 / -0.04 17.20M / - Beat!
November 4, 2016 -0.12 / -0.28 1.10M / - Beat!
May 5, 2016 -0.17 / -0.15 - / -
February 5, 2016 -0.15 / -0.16 - / -
Date Price Open High Low Vol Change
Feb 10 2.77 2.72
2.79
2.67
5.4K -0.36%
Feb 7 2.78 2.76
2.82
2.65
11.6K -1.07%
Feb 6 2.81 2.87
2.87
2.68
7.3K 0%
Feb 5 2.81 2.72
2.84
2.72
24.3K 0.72%
Feb 4 2.79 2.73
2.89
2.7
5.1K 1.09%
 
Feb 3 2.76 2.76
2.84
2.76
6.1K -3.16%
Jan 31 2.85 2.69
2.91
2.64
17.1K 1.79%
Jan 30 2.8 2.83
2.87
2.8
7.5K -2.78%
Jan 29 2.88 2.88
2.88
2.81
3.9K 0.35%
Jan 28 2.87 2.8
2.87
2.78
5.2K 0.35%
Jan 27 2.86 2.83
2.87
2.75
7.1K 0.35%
Jan 24 2.85 2.85
2.88
2.82
9.8K 1.06%
Jan 23 2.82 2.72
2.84
2.72
22.3K 1.81%
Jan 22 2.77 2.71
2.87
2.7
9.8K -2.12%
Jan 21 2.83 2.88
2.9
2.77
24.8K -1.39%
Jan 17 2.87 2.78
2.87
2.76
18.7K 3.61%
Jan 16 2.77 2.75
2.8
2.73
21.3K 0%
Jan 15 2.77 2.75
2.77
2.65
15.7K 0.73%
Jan 14 2.75 2.75
2.77
2.63
10.8K 1.10%
Jan 13 2.72 2.64
2.72
2.62
4.6K 0.74%
Jan 10 2.7 2.6
2.73
2.58
13.3K 0.37%
Jan 8 2.69 2.6
2.75
2.58
15.2K 3.46%
Jan 7 2.6 2.67
2.77
2.56
9.6K -2.99%
Jan 6 2.68 2.65
2.78
2.61
10.3K 0%
Jan 3 2.68 2.56
2.76
2.47
26.3K 5.10%
Jan 2 2.55 2.49
2.55
2.47
8.1K 3.66%
Dec 31, 2024 2.46 2.37
2.52
2.37
33.1K 0.41%
Dec 30, 2024 2.45 2.41
2.58
2.35
39.5K 0.41%
Dec 27, 2024 2.44 2.38
2.44
2.32
17.9K 2.52%
Dec 26, 2024 2.38 2.36
2.42
2.36
9.2K 0.85%
Dec 24, 2024 2.36 2.39
2.5
2.36
8.6K 0%
Dec 23, 2024 2.36 2.46
2.6
2.3
294K -5.6%
Dec 20, 2024 2.5 2.47
2.5
2.46
115K 2.04%
Dec 19, 2024 2.45 2.48
2.49
2.43
13.5K -2.78%
Dec 18, 2024 2.52 2.51
2.6
2.48
39.4K -3.08%
Dec 17, 2024 2.6 2.55
2.6
2.51
12.9K 0.78%
Dec 16, 2024 2.58 2.61
2.68
2.54
57.6K -4.44%
Dec 13, 2024 2.7 2.65
2.7
2.62
14.1K 0%
Dec 12, 2024 2.7 2.7
2.73
2.66
11.6K 0%
Dec 11, 2024 2.7 2.79
2.79
2.65
10.4K -3.57%
Dec 10, 2024 2.8 2.77
2.89
2.76
7.8K 0%
Dec 9, 2024 2.8 2.71
2.82
2.71
10.1K 3.70%
Dec 6, 2024 2.7 2.65
2.73
2.63
17.9K 0%
Dec 5, 2024 2.7 2.71
2.82
2.63
40.1K -1.1%
Dec 4, 2024 2.73 2.83
2.83
2.71
10.7K -1.44%
Dec 3, 2024 2.77 2.75
2.79
2.7
22.6K 0.73%
Dec 2, 2024 2.75 2.79
2.88
2.75
29.0K -2.48%
Nov 29, 2024 2.82 2.78
2.93
2.78
3.1K 0.71%
Nov 27, 2024 2.8 2.81
2.86
2.76
43.8K -1.41%
Nov 26, 2024 2.84 2.77
2.87
2.77
9.8K 2.90%
Nov 25, 2024 2.76 2.78
2.84
2.75
19.1K -0.72%
Nov 22, 2024 2.78 2.79
2.83
2.77
12.5K -1.07%
Nov 21, 2024 2.81 2.78
2.91
2.77
19.1K 0.36%
Nov 20, 2024 2.8 2.83
2.85
2.76
30.2K -2.1%
Nov 19, 2024 2.86 2.9
2.94
2.86
18.2K -0.69%
Nov 18, 2024 2.88 2.92
3
2.85
22.3K -1.37%
Nov 15, 2024 2.92 2.98
3.01
2.85
33.9K -2.99%
Nov 14, 2024 3.01 2.98
3.1
2.98
12.9K -0.66%
Nov 13, 2024 3.03 3.08
3.15
3.03
13.5K -3.5%
Nov 12, 2024 3.14 3.14
3.14
3.08
12.0K 0%